PM15 - A Novel Preoperative Risk Score to Optimize Patient Selection for Performing Concomitant Liver Resection with Cytoreductive Surgery/HIPEC
Sunday, February 16, 2020
9:30 AM – 9:45 AM
Location: Sebastian I 1/2
Background: While parenchymal hepatic metastases were previously considered a contraindication to cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC), liver resection (LR) is increasingly performed concomitantly with CRS/HIPEC. As this practice continues to expand, identification of preoperative factors associated with poor outcomes is paramount.
Methods: Patients from the US HIPEC Collaborative (2000-2017) with invasive appendiceal or colorectal adenocarcinoma undergoing primary, curative intent CRS/HIPEC with CC0-1 resection were included. Liver resection was defined as a formal parenchymal resection. Primary endpoints were postoperative complications and overall survival (OS).
Results: 658 patients were included. Average age was 54 years and 45% were male; 83 (15%) underwent liver resection of colorectal (58%) or invasive appendiceal (42%) metastases. Liver resection patients had more complications (81 vs 60%; p=0.001), greater number of complications (2.3 vs 1.5; p<0.001), and required more reoperations (22 vs 11%; p=0.007) and readmissions (39 vs 25%; p=0.014) than non-liver resection patients. Liver resection patients had decreased OS (2-year OS 62% vs 79%, p<0.001), which persisted on multivariable Cox regression when accounting for PCI and histology type. Preoperative factors associated with decreased OS on multivariable analysis in patients undergoing liver resection included age <60 years (HR:3.61), colorectal histology (HR:3.84), and multiple liver tumors (HR:3.45) (all p<0.05). When assigning one point for each factor, there was an incremental decrease in 2-yr survival as the risk score increased from 0 to 3 (0: 100%; 1: 91%; 2: 58%; 3: 0%; p<0.001).
Conclusions: As concurrent liver resection with CRS/HIPEC has become more common, we created a simple risk score to stratify patients considered for CRS/HIPEC with liver resection. These data aid in striking the balance between an increased perioperative complication profile with the potential for improvement in overall survival.